104 related articles for article (PubMed ID: 8721090)
1. [Cancer chemosensitivity test--from laboratory to clinic].
Kubota T
Hum Cell; 1995 Dec; 8(4):189-94. PubMed ID: 8721090
[TBL] [Abstract][Full Text] [Related]
2. [Effects of chemotherapy on the basis of the results of MTT assay for patients with gastrointestinal cancer].
Yamaue H; Tanimura H
Hum Cell; 1995 Dec; 8(4):185-8. PubMed ID: 8721089
[TBL] [Abstract][Full Text] [Related]
3. Clinical applications of the histoculture drug response assay.
Furukawa T; Kubota T; Hoffman RM
Clin Cancer Res; 1995 Mar; 1(3):305-11. PubMed ID: 9815986
[TBL] [Abstract][Full Text] [Related]
4. [Chemosensitivity test for gastric carcinoma].
Kubota T
Gan To Kagaku Ryoho; 1997 Feb; 24(4):495-500. PubMed ID: 9063490
[TBL] [Abstract][Full Text] [Related]
5. [Clinical studies of in vitro chemosensitivity test evaluated by ATP assay of gastrointestinal cancer].
Jinushi K; Hirabayashi N; Kirihara Y; Takagami S; Ryuji K; Yorishima T; Nishiyama M; Noso Y; Toge T
Gan To Kagaku Ryoho; 1990 Nov; 17(11):2235-9. PubMed ID: 2122811
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of the ATP chemosensitivity assay in epithelial ovarian cancer.
O'Meara AT; Sevin BU
Gynecol Oncol; 2001 Nov; 83(2):334-42. PubMed ID: 11606094
[TBL] [Abstract][Full Text] [Related]
7. Cumulative results of chemosensitivity tests for antitumor agents in Japan. Japan Research Society for Appropriate Cancer Chemotherapy.
Kondo T; Kubota T; Tanimura H; Yamaue H; Akiyama S; Maehara Y; Tanigawa N; Kitajima M; Takagi H
Anticancer Res; 2000; 20(4):2389-92. PubMed ID: 10953301
[TBL] [Abstract][Full Text] [Related]
8. Chemosensitivity testing of primary tumor cells from gastric cancer patients with liver metastasis can identify effective antitumor drugs.
Kurihara N; Kubota T; Furukawa T; Watanabe M; Otani Y; Kumai K; Kitajima M
Anticancer Res; 1999; 19(6B):5155-8. PubMed ID: 10697526
[TBL] [Abstract][Full Text] [Related]
9. In vitro chemosensitivity test for human genito-urinary tumors using collagen gel matrix.
Koshida K; Egawa M; Imao T; Mizokami A; Namiki M; Endo Y; Sasaki T
Int J Urol; 2005 Jan; 12(1):67-72. PubMed ID: 15661056
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of optimal drug concentration in histoculture drug response assay in association with clinical efficacy for head and neck cancer.
Hasegawa Y; Goto M; Hanai N; Ijichi K; Adachi M; Terada A; Hyodo I; Ogawa T; Furukawa T
Oral Oncol; 2007 Sep; 43(8):749-56. PubMed ID: 17112769
[TBL] [Abstract][Full Text] [Related]
11. A prospective randomized controlled trial of tumour chemosensitivity assay directed chemotherapy versus physician's choice in patients with recurrent platinum-resistant ovarian cancer.
Cree IA; Kurbacher CM; Lamont A; Hindley AC; Love S;
Anticancer Drugs; 2007 Oct; 18(9):1093-101. PubMed ID: 17704660
[TBL] [Abstract][Full Text] [Related]
12. [Chemosensitivity test and its clinical application].
Inoue K
Gan No Rinsho; 1989 Oct; 35(13):1535-40. PubMed ID: 2685394
[TBL] [Abstract][Full Text] [Related]
13. Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer.
Konecny G; Crohns C; Pegram M; Felber M; Lude S; Kurbacher C; Cree IA; Hepp H; Untch M
Gynecol Oncol; 2000 May; 77(2):258-63. PubMed ID: 10785475
[TBL] [Abstract][Full Text] [Related]
14. Chemosensitivity testing for gastrointestinal cancer: survival benefit potential and limitations.
Kim R; Emi M; Tanabe K; Uchida Y; Toge T
Anticancer Drugs; 2003 Oct; 14(9):715-23. PubMed ID: 14551504
[TBL] [Abstract][Full Text] [Related]
15. Chemosensitivity testing of clinical gastrointestinal cancers using histoculture and the MTT end-point.
Furukawa T; Kubota T; Watanabe M; Kase S; Takahara T; Yamaguchi H; Takeuchi T; Teramoto T; Ishibiki K; Kitajima M
Anticancer Res; 1992; 12(5):1377-82. PubMed ID: 1444194
[TBL] [Abstract][Full Text] [Related]
16. [Chemosensitivity test for unresectable non-small cell lung cancer].
Kawamura M; Inoue Y; Oyama T; Kobayashi K
Nihon Geka Gakkai Zasshi; 2002 Feb; 103(2):229-32. PubMed ID: 11904985
[TBL] [Abstract][Full Text] [Related]
17. [Predicting clinical chemo-sensitivity of primary ovarian cancer using adenosine triphosphate-tumor chemosensitivity assay combined with detection of drug resistance genes].
Zhao D; Zhang W; Li XG; Wang XB; Zhang LF; Li M; Li YF; Tian HM; Song PP; Liu J; Chang QY; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):193-8. PubMed ID: 21575453
[TBL] [Abstract][Full Text] [Related]
18. [Clinical criteria of chemosensitivity test].
Kubota T; Otani Y; Watanabe M; Kitajima M
Nihon Rinsho; 1997 May; 55(5):1050-3. PubMed ID: 9155151
[TBL] [Abstract][Full Text] [Related]
19. [Chemosensitivity testing of fresh human gastrointestinal cancers using AgNOR assay].
Gu P
Zhonghua Zhong Liu Za Zhi; 1993 Nov; 15(6):438-40. PubMed ID: 8200282
[TBL] [Abstract][Full Text] [Related]
20. [Clinical study of clonogenic assays--with reference to adjuvant cancer chemotherapy after operation].
Kubota T; Kawamura E; Kurihara H; Ishibiki K; Abe O
Nihon Geka Gakkai Zasshi; 1986 Feb; 87(2):154-61. PubMed ID: 3713670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
